Pharmafile Logo

OPEN Health at ECRD 2020

May 14, 2020 | #ECRD2020, rare, virtualevents 

Gavin Jones shares his thoughts on why congress is so important at this time and the key sessions he is looking forward to.

Our Director of Rare Disease, Gavin Jones, is looking forward to spending the next two days at the #ECRD2020 congress.  It’s going to be a busy few days with highlights for Gavin being sessions on achieving faster diagnosis, innovation with advanced therapies and the future of specialised services.   He will report back so watch this space.

To keep sustained today Gavin is snacking on fruit, chocolate and cold brew tea (who has time to boil a kettle?). He is also delighted that this is the first time he has been able to bring his beloved Eddie to a congress!

If you are there, send Gavin a chat message through the congress platform to connect.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....

Spotlight interview: 15 minutes on insights and market research in pharma

Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma

OPEN Health reflections on the World Orphan Drug Congress in Barcelona

Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications...

Patient journey mapping: exploring the clinical and the emotional journey

By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...

OPEN Health announces the integration of Pharmerit International into the group

OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.

OPEN Health mobilised to support outcomes with gene and other advanced therapies

Harnessing the power of collaborations to bring real insights and improve outcomes

Spotlight interview: 15 minutes on PR in pharma

Vicky Bramham, Managing Director, OPEN Health takes 15 minutes to answer some key questions on PR discipline.

OPEN Health PBC recognised as No. 1 independent creative agency

We’re No.1! PMLive have named OPEN Health Patient & Brand Communications as the no.1 independent creative healthcare agency. The aim of the PMLive Top 10 lists is to highlight those...

Spotlight interview: 15 minutes on medical and scientific writing

Rob Pilbrow, Global Managing Director, Medical Writing, OPEN Health takes 15 minutes to answer some key questions on scientific writing

Spotlight interview: 15 minutes on healthcare advertising

Marie Little, Managing Director, OPEN Health Patient & Brand Communications takes 15 minutes to answer some key questions on healthcare advertising